Results 231 to 240 of about 115,857 (253)

Myeloproliferative neoplasms (MPNs)

Blood Reviews, 2020
openaire   +2 more sources

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Histopathology, 2021
Štefan Porubský, Maike Büttner-Herold, Carsten Sticht   +2 more
exaly  

Myeloproliferative neoplasms – a global view

British Journal of Haematology, 2022
Ayalew Tefferi, Jean‐Christophe Ianotto, Vikram Mathews, Jan Samuelsson, Natasha Szuber, Zhijian Xiao, Peter Hokland   +6 more
openaire   +3 more sources

Advances in Understanding and Management of Myeloproliferative Neoplasms†‡§

Ca-A Cancer Journal for Clinicians, 2009
Alessandro Maria Vannucchi, Paola Guglielmelli, Ayalew Tefferi   +2 more
exaly  

Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms

Cancer Cell, 2018
Keith Cordner, Franck Rapaport, Corinne E Hill   +2 more
exaly  

Myeloproliferative neoplasms

2022
Angela Fleischman, Kristen Pettit
openaire   +1 more source

Inherited predisposition to myeloproliferative neoplasms

Therapeutic Advances in Hematology, 2013
Nicholas Cross, Amy V Jones
exaly  

Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms

Leukemia and Lymphoma, 2012
Ruben Mesa, Gunnar Birgegard
exaly  

3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

Mayo Clinic Proceedings, 2019
Rhett P. Ketterling, Mrinal M Patnaik, Terra L Lasho   +2 more
exaly  

Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001–12

British Journal of Haematology, 2016
Lindsay M Morton
exaly